(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 8.57% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 3.16%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.37%.
Stepan Co's revenue in 2025 is $2,180,274,000.On average, 2 Wall Street analysts forecast SCL's revenue for 2025 to be $51,826,981,451, with the lowest SCL revenue forecast at $50,769,287,952, and the highest SCL revenue forecast at $52,884,674,950.
In 2026, SCL is forecast to generate $54,842,533,129 in revenue, with the lowest revenue forecast at $53,829,847,864 and the highest revenue forecast at $55,855,218,394.